全球动物用药品配製市场规模、份额、趋势和成长分析报告（2026-2034）

预计动物用药品配製市场将从 2025 年的 31 亿美元成长到 2034 年的 67 亿美元，2026 年至 2034 年的复合年增长率为 8.93%。

受个人化兽医护理需求不断增长以及宠物和牲畜慢性病日益普遍的推动，动物用药品配製市场正经历显着增长。随着宠物饲养量的增加和动物健康意识的提高，兽医越来越多地转向配製药房，以配製满足个别动物特定需求的定製药物。当非处方药因剂量、剂型或口味偏好等原因不适用时，这种趋势尤其明显。定製药物的能力提高了遵守用药，使动物用药品配製市场成为现代兽医护理的关键组成部分。

此外，製药技术和法规结构的进步正在推动兽用复方製剂市场的成长。更严格的品质标准和指南的实施确保了复方製剂的安全、有效和可靠。随着兽医专业人员对复方製剂益处的认识不断加深，预计市场将进一步扩大，越来越多的兽医诊所将复方製剂服务纳入其诊疗范围。此外，远端医疗在兽医领域的兴起也为复方製剂药局创造了新的机会，使其能够触达更广泛的客户群体，实现远距咨询和个人化药物配送。

动物用药品配製市场也在製剂技术方面不断创新，致力于开发新的给药方式，以提高药物的偏好和疗效。添加香料、经皮系统以及缓释製剂的引入，只是配製药房为满足兽医学不断变化的需求而采取的几种方式。随着市场在消费者需求、技术进步和监管支持的共同推动下持续成长，动物配製药的未来有望保障动物的健康和福祉，并提高医疗照护品质。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球动物用药品配製市场（以动物类型划分）

• 市场分析、洞察与预测
• 伴侣动物
• 家畜

5. 全球动物用药品配製市场（依药物类型划分）

• 市场分析、洞察与预测
• 抗感染剂
• 抗发炎药
• 荷尔蒙及其替代品
• 中枢神经系统药物
• 其他药物类型

6. 全球动物用药品复方製剂市场（以剂型划分）

• 市场分析、洞察与预测
• 口服药物（片剂、胶囊、液体和其他口服药物）
• 外用药物（软膏、乳霜、凝胶、喷雾）
• 注射
• 其他剂型

7. 全球动物用药品配製剂市场（依分销管道划分）

• 市场分析、洞察与预测
• 兽医诊所和药房
• 配药药房
• 其他分销管道

8. 全球动物用药品配药市场（按地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • AVRIO Pharmacy
  • New Era Pharmacy
  • NexGen Pharmaceuticals
  • Pace Pharmacy
  • SaveWay Compounding Pharmacy
  • ScriptWorks
  • SCIRx Pharmacy
  • Summit Veterinary Pharmacy Ltd
  • Triangle Compounding Pharmacy
  • The Pet Apothecary
  • Veterinary Pharmaceutical Solutions
  • Veterinary Specialty Pharmacy
  • Wedgewood Pharmacy

The Animal Drug Compounding Market size is expected to reach USD 6.70 Billion in 2034 from USD 3.10 Billion (2025) growing at a CAGR of 8.93% during 2026-2034.

The animal drug compounding market is experiencing a notable surge, driven by the increasing demand for personalized veterinary care and the growing prevalence of chronic diseases in pets and livestock. As pet ownership rises and animal health awareness grows, veterinarians are increasingly turning to compounding pharmacies to create tailored medications that meet the specific needs of individual animals. This trend is particularly significant in cases where commercially available drugs may not be suitable due to dosage, formulation, or flavor preferences. The ability to customize medications enhances treatment efficacy and compliance, positioning the animal drug compounding market as a vital component of modern veterinary practice.

Furthermore, advancements in pharmaceutical technology and regulatory frameworks are facilitating the growth of the animal drug compounding market. The introduction of more stringent quality standards and guidelines is ensuring that compounded medications are safe, effective, and reliable. As veterinary professionals become more educated about the benefits of compounded drugs, the market is likely to expand, with an increasing number of veterinary practices incorporating compounding services into their offerings. Additionally, the rise of telemedicine in veterinary care is creating new opportunities for compounding pharmacies to reach a broader clientele, allowing for remote consultations and customized medication delivery.

The animal drug compounding market is also witnessing innovation in formulation techniques, with a focus on developing new delivery methods that enhance the palatability and efficacy of medications. The incorporation of flavoring agents, transdermal delivery systems, and sustained-release formulations are just a few examples of how compounding pharmacies are adapting to meet the evolving needs of veterinary medicine. As the market continues to grow, driven by a combination of consumer demand, technological advancements, and regulatory support, the future of animal drug compounding promises to enhance the quality of care for animals, ensuring their health and well-being.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal Type

• Companion Animals
• Livestock Animals

By Drug Type

• Anti-Infective Agents
• Anti-Inflammatory Agents
• Hormones & Substitutes
• CNS Agents
• Other Drug Types

By Dosage Form

• Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms)
• Topical (Ointments, Creams, Gels, Sprays)
• Injectable
• Other Dosage Forms

By Distribution Channel

• Veterinary Hospitals Pharmacies
• Compounding Pharmacies
• Other Distribution Channels

COMPANIES PROFILED

• AVRIO Pharmacy, New Era Pharmacy, NexGen Pharmaceuticals, Pace Pharmacy, SaveWay Compounding Pharmacy, ScriptWorks, SCIRx Pharmacy, Summit Veterinary Pharmacy Ltd, Triangle Compounding Pharmacy, The Pet Apothecary, Veterinary Pharmaceutical Solutions, Veterinary Specialty Pharmacy, Wedgewood Pharmacy

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY ANIMAL TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Animal Type
• 4.2. Companion Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Livestock Animals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Drug Type
• 5.2. Anti-Infective Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Anti-Inflammatory Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hormones & Substitutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. CNS Agents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Drug Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DOSAGE FORM 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Dosage Form
• 6.2. Oral (Tablets, Capsules, Liquids, Other Oral Dosage Forms) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Topical (Ointments, Creams, Gels, Sprays) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Injectable Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Other Dosage Forms Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Distribution Channel
• 7.2. Veterinary Hospitals Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Compounding Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Other Distribution Channels Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ANIMAL DRUG COMPOUNDING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Animal Type
  • 8.2.2 By Drug Type
  • 8.2.3 By Dosage Form
  • 8.2.4 By Distribution Channel
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Animal Type
  • 8.3.2 By Drug Type
  • 8.3.3 By Dosage Form
  • 8.3.4 By Distribution Channel
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Animal Type
  • 8.4.2 By Drug Type
  • 8.4.3 By Dosage Form
  • 8.4.4 By Distribution Channel
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Animal Type
  • 8.5.2 By Drug Type
  • 8.5.3 By Dosage Form
  • 8.5.4 By Distribution Channel
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Animal Type
  • 8.6.2 By Drug Type
  • 8.6.3 By Dosage Form
  • 8.6.4 By Distribution Channel
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ANIMAL DRUG COMPOUNDING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 AVRIO Pharmacy
  • 10.2.2 New Era Pharmacy
  • 10.2.3 NexGen Pharmaceuticals
  • 10.2.4 Pace Pharmacy
  • 10.2.5 SaveWay Compounding Pharmacy
  • 10.2.6 ScriptWorks
  • 10.2.7 SCIRx Pharmacy
  • 10.2.8 Summit Veterinary Pharmacy Ltd
  • 10.2.9 Triangle Compounding Pharmacy
  • 10.2.10 The Pet Apothecary
  • 10.2.11 Veterinary Pharmaceutical Solutions
  • 10.2.12 Veterinary Specialty Pharmacy
  • 10.2.13 Wedgewood Pharmacy